BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1856347)

  • 1. Immunohistochemical demonstration of actinically damaged elastic fibers in keratoacanthomas: an aid in diagnosis.
    Jordan RC; Kahn HJ; From L; Jambrosic J
    J Cutan Pathol; 1991 Apr; 18(2):81-6. PubMed ID: 1856347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas.
    Schnur PL; Bozzo P
    Plast Reconstr Surg; 1978 Aug; 62(2):258-62. PubMed ID: 674415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
    King DF; Barr RJ
    J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: an immunohistochemical aid to diagnosis.
    Krunic AL; Garrod DR; Smith NP; Orchard GS; Cvijetic OB
    Acta Derm Venereol; 1996 Sep; 76(5):394-8. PubMed ID: 8891017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are keratoacanthomas really squamous cell carcinomas?
    Sanders GH; Miller TA
    Ann Plast Surg; 1982 Oct; 9(4):306-9. PubMed ID: 7149561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
    Ho T; Horn T; Finzi E
    Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma.
    Ohashi A; Ishizaki M; Kawana S; Fukuda Y
    Pathol Int; 2004 Aug; 54(8):585-94. PubMed ID: 15260849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating keratoacanthoma from squamous cell carcinoma of the lower lip: an analysis of intraepithelial elastic fibers and intracytoplasmic glycogen.
    Ellis GL
    Oral Surg Oral Med Oral Pathol; 1983 Nov; 56(5):527-32. PubMed ID: 6580597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma.
    Kannon G; Park HK
    Am J Dermatopathol; 1990 Feb; 12(1):31-6. PubMed ID: 2180338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma.
    Beham A; Regauer S; Soyer HP; Beham-Schmid C
    Adv Anat Pathol; 1998 Sep; 5(5):269-80. PubMed ID: 10021894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
    Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
    Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratoacanthoma and squamous cell carcinoma of the skin: immunohistochemical localization of involucrin and keratin proteins.
    Smoller BR; Kwan TH; Said JW; Banks-Schlegel S
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):226-34. PubMed ID: 2419374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
    Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma?
    Mandrell JC; Santa Cruz D
    Semin Diagn Pathol; 2009 Aug; 26(3):150-63. PubMed ID: 20043514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating keratoacanthoma from squamous cell carcinoma-In quest of the holy grail.
    Nagarajan P
    J Cutan Pathol; 2020 Apr; 47(4):418-420. PubMed ID: 31893469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas.
    Jensen P; Clausen OP; Bryne M
    J Cutan Pathol; 1999 Apr; 26(4):183-9. PubMed ID: 10335895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression.
    Strieth S; Hartschuh W; Pilz L; Fusenig NE
    Br J Cancer; 2002 Nov; 87(11):1301-7. PubMed ID: 12439721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical sweat duct hyperplasia accompanying keratoacanthoma.
    Santa Cruz DJ; Clausen K
    Dermatologica; 1977; 154(3):156-60. PubMed ID: 856645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.